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Abstract

Transgenerational effects of environmental toxins require either a chromosomal or epigenetic
alteration in the germ line. Transient exposure of a gestating female rat during the period
of gonadal sex determination to the endocrine disruptors vinclozolin (an antiandrogenic
compound) or methoxychlor (an estrogenic compound) induced an adult phenotype in the
F1 generation of decreased spermatogenic capacity (cell number and viability) and increased
incidence of male infertility. These effects were transferred through the male germ line to
nearly all males of all subsequent generations examined (that is, F1 to F4). The effects on
reproduction correlate with altered DNA methylation patterns in the germ line. The ability
of an environmental factor (for example, endocrine disruptor) to reprogram the germ line
and to promote a transgenerational disease state has significant implications for evolutionary
biology and disease etiology.

Treatments, such as irradiation and chemotherapy, and compounds, such as environmental toxins, pose a threat to the integrity of
the genome. Studies have shown that these
agents can result in genetic or developmental defects in the offspring or F1 generation
from an exposed gestating mother. The ability of an external agent to induce a transgenerational effect requires stable chromosomal
alterations or an epigenetic phenomenon such
as DNA methylation (1). In the present study,
transgenerational refers to a germline transmission to multiple generations, minimally to
the F2 generation. Transgenerational effects
of irradiation were the first to be identified
through transmission of DNA mutations in
the germ line to multiple generations (2), often associated with tumor formation. Chemotherapeutic treatments (3) and environmental toxins such as endocrine disruptors (4) can
cause effects in the F1 generation, but they
have not been shown to affect the F2 generation. Although no effects have been shown
to be transgenerational, the potential impact
of such transgenerational effects of endocrine
disruptors has been discussed (5).
Epigenetic alterations that could lead to
transgenerational transmission of specific genetic traits have recently been identified (1,
6). A transgenerational phenotype or genetic
trait requires a permanent reprogramming
of the germ line. During mammalian germ
cell development the methylation state of
the genome is reprogrammed. As primordial
germ cells (PGCs) migrate down the genital

ridge, a demethylation starts and is complete on colonization in the early gonad (7,
8). Germ cells in the gonad then undergo remethylation in a sex-specific manner during
gonadal sex determination (9). Although demethylation may not require the gonadal somatic cells, remethylation of the germ line
appears to be dependent on association with
the somatic cells in the gonads (7). Gonadal
sex determination and testis development
occur between embryonic days 12 and 15
(E12 to E15) in the rat (after midgestation in
the human) and are initiated by the differentiation of precursor Sertoli cells in response
to the testis-determining factor Sry. Aggregation of the precursor Sertoli cells, PGCs,
and migrating mesonephros cells (precursor peritubular myoid cells) promotes testis morphogenesis and cord formation (10,
11). During the period of gonadal sex determination, the fetal testis contains steroid receptors and is a target for endocrine agents.
The androgen receptor (AR) and estrogen
receptor–β (ERβ) are present in Sertoli cells,
precursor peritubular myoid cells, and germ
cells at the time of cord formation (E14)
(12, 13). Although steroids are not produced
by the testis at this stage of development, estrogenic and androgenic substances have the
ability to influence early testis cellular functions. Therefore, steroidal factors acting inappropriately at the time of gonadal sex determination potentially could reprogram
the germ line through an epigenetic mechanism (altered DNA methylation) to cause the
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transgenerational transmission of an altered
phenotype or genetic trait.
The estrogenic and antiandrogenic endocrine disruptors used in the current study are
methoxychlor and vinclozolin, respectively.
Vinclozolin is a commonly used fungicide
in the wine industry that is metabolized into
more active (i.e., higher affinity binding to androgen receptor) compounds (14). Methoxychlor is used as a pesticide to replace DDT
and is metabolized into active compounds
with the ERα agonist, the ERβ antagonist, and
anti-androgenic activity (15–17). Vinclozolin
or methoxychlor exposure in the late embryonic or early postnatal period influences sexual differentiation, gonad formation, and reproductive functions in the F1 generation (14,
18, 19). Transient exposure (daily intraperitoneal injection of 100 or 200 mg/kg dose)
of a gestating female rat to methoxychlor or
vinclozolin between E8 and E15 promotes
reduced spermatogenic capacity associated
with increased spermatogenic cell apoptosis
and decreased sperm number and motility in
the adult F1 generation (20, 21). A similar exposure between E15 and E20 had no effect on
the F1 generation testis (20, 21). These observations were extended in the present study by
treating the gestating mother with vinclozolin. F1 generation male rats were mated with
F1 generation females from different litters.
Subsequent breeding continued for four generations with sufficient numbers of animals to
avoid sibling inbreeding. Adult males from
F1, F2, F3, and F4 generations between postnatal days PND60 and PND180 were killed.
Testes were isolated for histological examination, and caudal epididymal sperm were
collected for sperm counts and motility measurements. Only the original gestating mother
(F0) of the F1 generation received a transient
endocrine disruptor treatment. Control groups
of animals were bred in a similar manner after vehicle treatment (dimethylsulfoxide buffer alone injected) of the F0 gestating mother.
Analysis of cellular apoptosis demonstrated
a greater than two-fold increase in spermatogenic cell apoptosis in the vinclozolin treatment animals for the F1 to F4 generations
(Figure 1A). Sperm numbers were reduced
minimally, 20%, and sperm forward motility
was reduced about 25 to 35% for vinclozolin
generation animals (Figure 1, B and C). More
than 90% of all males analyzed from all generations had the germ cell defect of increased
spermatogenic cell apoptosis. Therefore, the
frequency of the phenotype was >90% and
did not decline between the F1 and F4 generations. A similar experiment was performed
with methoxychlor. After transient embryonic
methoxychlor exposure (E8 to E15), a similar
phenotype was observed in both the F1 and F2
animals (fig. S1). Therefore, both vinclozolin
and methoxychlor induced transgenerational
defects in spermatogenic capacity and sperm
viability.
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An outcross experiment was performed to
determine whether the transgenerational phenotype was transmitted through the male germ
line. Vinclozolin F2 generation males (i.e.,
male progeny from an F0 treated mother) were
crossed with wild-type untreated control females, and the offspring were analyzed. The
vinclozolin outcross (VOC) male progeny also
had an increase in spermatogenic cell apoptosis and a decrease in sperm number and motility (Figure 1). The reverse vinclozolin outcross (RVOC) with vinclozolin F2 generation
females and wild-type control males demonstrated no effect on the spermatogenic cells
(Figure 1). Therefore, the endocrine disruptor–
induced transgenerational phenotype appears
to be transmitted through the male germ line.
The morphology of the testes from control and treated rats was similar for all animals examined on PND60 in all F1 to F4 vinclozolin generations. Periodically, male rats
older than 90 days of age developed complete infertility associated with small testis
and severely reduced spermatogenesis, which
was not seen in the PND60 animals. This occurred in 4 out of a total of 50 F1, F2, F3, and
F4 generation animals. Therefore, 8% of the
vinclozolin transgenerational males developed complete infertility. None of the 42 control F1 to F4 generation animals were infertile. The testis histology for a representative
infertile vinclozolin F3 generation animal is
shown in Figure 2 and demonstrates a loss of
normal spermatogenesis (no germ cells present) and abnormal seminiferous tubule morphology. The control F3 male showed normal
morphology with normal spermatogenesis.
Although most of the animals older than 90
days of age were fertile, 20% developed a
dramatic decrease in spermatogenic capacity (50% of the tubules having impaired germ
cell development) in all the generations examined. The VOC males also had increased
infertility in 20% of the animals over 90
days of age. The treated males that were fertile showed no change in litter size, newborn pup weights, or testis weight per body
weight when compared with the control animals of any of the F1 to F4 generations examined. Nearly all the treated male progeny had
the minimal phenotype of twofold increase in
spermatogenic cell apoptosis, and the majority had a decrease in epididymal sperm number (Figure 1, A and B).
The transmission of this endocrine disruptor–induced testis phenotype in a transgenerational manner suggests an epigenetic
alteration of the male germ line. The frequency observed for the phenotype (>90%
of all males in all generations) cannot be explained through genetic DNA sequence mutational mechanisms. A high-frequency genetic (DNA sequence) mutation hotspot event
would be an order of magnitude less than that
observed (2, 22, 23). Subsequent segregation
of this mutation would likely result in a reduction of the phenotype frequency with each

and

M ale F ertility

generation. In addition, the random nature of
genetic (DNA sequence) mutations is generally more variable in the phenotype observed
(2, 22, 23). In contrast, an epigenetic mechanism involving reprogramming of the germ
line could result in the high frequency observed. In addition, the developmental period
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used for the endocrine disruptor exposure
was during the remethylation programming
of the germ line. Although we cannot exclude
the possibility of a novel genetic (DNA sequence) mutational event, available information suggests an epigenetic mechanism is involved.

Figure 1. Transgenerational phenotype after
vinclozolin treatment of F0 gestating mothers.
(A) Spermatogenic cell apoptosis, (B) epididymal sperm counts, and (C) epididymal sperm
motility in PND60 to 180 control and vinclozolin off-spring Sprague-Dawley rats in the F1,
F2, F3, and F4 generations, and vinclozolin F2
generation male outcross (VOC) to wild-type
control females, and vinclozolin F2 generation
female reverse outcross (RVOC) to wild-type
control males. Statistically significant differences between control and vinclozolin treatment generations are indicated by (*) for P <
0.001 with a two-way analysis of variance test.
The n value for each bar ranged between 10
and 30 animals. Detailed methods are provided in Supporting Materials (below).
Figure 2. Testis histology
from control (A) and vinclozolin treatment (B) 100-dayold F3 generation animals, ×
200 magnification. The vinclozolin F3 generation male
is a representative infertile
male. Arrow in (A) identifies
the tails of elongate spermatozoa in the seminiferous
tubule lumen; arrowhead labels spermatocytes in the
tubule epithelial layer. Arrow in (B) identifies the lack
of germ cells in the seminiferous tubule. Methods are
provided in Supporting Materials (below).
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Figure 3. DNA methylation analysis from control and vinclozolin offspring testis. (A) Representative gel images of the PCR-based methylation-sensitive Hpa II restriction enzyme digest analysis with representative band (arrow) affected in PND6 testis from control and vinclozolin treatment animals.
Each lane represents a different individual animal (n = 4). (B) Location of selected sequences on specific chromosomes for two representative DNA
sequences with altered DNA methylation patterns termed clone 7 and 17. (C) Methylation-sensitive restriction enzyme PCR analysis of the methylation state of clone 17 (i.e., cytokine-inducible SH2 protein) gene in epididymal sperm from F2 and F3 generations from control and vinclozolin-treated
animals. The bands presented are representative of sperm DNA collected from different animals from different litters and are consistent in four out of
eight F2 animals and two out of five F3 animals analyzed. Methods are provided in Supporting Materials (below).

The only epigenetic mechanism currently
known to influence germline transmission involves the methylation pattern of imprinted
genes. This study does not investigate specific known imprinted genes, but focuses on
the effects of the endocrine disruptor on the
total genome. Fisher rats were used because
of reduced polymorphisms, which made
methylation studies more consistent and reproducible. PND6 testes were collected from
male F1 progeny of vinclozolin-treated and
control rats. A methylation-sensitive restriction enzyme digestion analysis involving a
polymerase chain reaction (PCR)–based procedure was used to assess changes in DNA
methylation patterns (Methods in SOM). Animals (n = 4) from different litters of control
and treated animals were analyzed. The vinclozolin-induced methylation patterns were
similar in the replicate animals. About 25 different PCR products were identified that had
altered DNA methylation patterns after the
endocrine disruptor treatment. A representative change in methylation pattern is shown
in Figure 3A and fig. S2. These methylation
experiments were extended by isolating and
cloning several of the DNA fragments with
apparent altered methylation. Two of the
DNA fragments were sequenced and mapped
to CpG-rich regions on chromosomes 6q32
and 8q32 (Figure 3B). Clone 7 mapped to
6q32 and was within the lysophospholipase (LPLase) gene (accession NM144750).
LPLase is a critical enzyme in the synthesis of important bioactive lipids and associated signaling (24). Clone 17 mapped to 8q32
and is within 1 kb of the start site of an uncharacterized protein termed cytokine-inducible SH2 protein (accession AJ243907 [GenBank]). Whether the genes identified are

causal factors or simply markers (i.e., downstream) of the transgenerational epigenetic
pheno-type remains to be determined.
The epigenetic transgenerational transmission of the altered methylation pattern
through the male germ line was investigated.
PCR primers were designed for the flanking
regions of the clone 17 gene, cytokine-inducible SH2 protein and were used to investigate
altered methylation with the methylation-sensitive restriction enzyme digest procedure.
Epididymal sperm were isolated from vinclozolin treatment F2 and F3 generation animals.
As shown in Figure 3C, the control animals
had the PCR product, whereas the vinclozolin treatment F2 and F3 animals did not. The
control Rsa I digest had a PCR product in all
samples. Therefore, the vinclozolin treatment
F2 and F3 generation sperm samples appeared
to have altered DNA methylation in this clone
17 gene compared with control animal sperm.
An alternate bisulfite DNA sequence analysis
was used to confirm the methylation changes.
Bisulfite analysis confirmed the altered methylations of the LPLase gene within the CpG
island identified. This bisulfite altered sequence (fig. S3) was observed in ~25% of
the vinclozolin treatment sperm DNA samples analyzed. A single-gene methylation
event alone is not likely sufficient to promote
the phenotype, but could cause alterations in
a subset of genes. For example, 25 DNA sequences with altered methylation were identified, and if a random subset of genes with
altered methylation promotes the phenotype,
a 25% frequency for altered methylation of
a single gene would be significant. Observations indicate that the endocrine disruptors
can induce an epigenetic transgenerational
change in the DNA methylation pattern of

the male germ line. The epigenetic alterations
observed involve both hypermethylation and
hypomethylation events.
Two different endocrine disruptors, vinclozolin and methoxychlor, after a transient
embryonic exposure at a critical time during gonadal sex determination (E8 to E15
in the rat), promoted an adult testis phenotype of decreased spermatogenic capacity
and male infertility. No gross abnormality
was observed in any other tissues examined,
and serum testosterone levels were found to
be normal in all the animals examined. This
phenotype was found to be transgenerational
and appears associated with altered DNA
methylation of the male germ line. The phenotype was observed in nearly all males
from all vinclozolin generations, such that
a genetic mutation event (e.g., alteration in
DNA sequence) is not likely to be a major
factor. The frequency of a genetic mutation
would be orders of magnitude less than the
transmission frequency observed in the current study (2, 22, 23). Preliminary data demonstrate no major effect on the female, but
a number of abnormal pregnancy outcomes
were observed in pregnant females from offspring of vinclozolin-treated animals, but
not controls. The abnormal phenotype has
similarities to preeclampsia that include
death, severe anemia, and blood cell defects.
This study shows that environmental factors
can induce an epigenetic transgenerational
phenotype through an apparent reprogramming of the male germ line. It should be
noted that the exposure levels used in these
studies are higher than anticipated for environmental exposure; hence, future toxicology studies would be needed to ascertain the
possible impact on animal populations.
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MATERIALS & METHODS
A. In Vivo Procedures
Gestating outbred Sprague-Dawley and inbred Fisher mother rats from timed pregnant
colonies housed at the Washington State University Vivarium were given intraperitoneal
injections of vinclozolin (100 mg/kg per day) and methoxychlor (200 mg/kg/day) from
embryonic day 8-15 (E8-E15) of gestation (F0 generation) as previously described (S1).
Sperm positive vaginal smear date being embryonic day 0. Gestating control mothers
received vehicle alone (i.e. sesame oil or DMSO). At least 6 lines (individual F0 injected
females) were generated for controls and treated groups for these analyses. Male rats from
control and treated groups were collected at P60-P180 for analyses. F1 treated males were
bred to F1 treated females to generate the F2 treated generation and F2 treated males were
bred to F2 treated females to generate the F3 generation and the F3 were bred in the same
manner to generate the F4 generation. Rats for the control groups were bred in the same
manner for all the generations. No inbreeding or sibling crosses were generated. The
outcross group (VOC) was generated by breeding the F2 treated males with wild-type
females (total of 6 litters) and reverse outcross group (RVOC) was generated by breeding
F2 treated females with wild-type males (total of 3 litters). Control (n = 4) and treated (n =
4) male offspring from the F1 generation from Fisher strain rats were collected at P6 for
DNA methylation analysis, see below. All procedures have been approved by the
Washington State University Animal Use and Care Committee. The numbers of animals
used for replicates in the experiments (i.e., n value) for vinclozolin treatment are as
follows: F1 (control 11, treated 12); F2 (control 19, treated 30); F3 (control 19, treated 26);
F4 (control 15, treated 21); outcrosses (VOC 18, RVOC 6, wild-type controls 8). The
methoxychlor treatment animal number was for F1 (control 6, treated 9) and F2 (control 16,
treated 22).

Science Supporting Online Material
Anway et al., p. 2

B. Sperm Motility and Concentration Analysis
Animals were sacrificed and cauda epididymal sperm motility was determined using
cauda epididymal sperm. Briefly, the epididymis was dissected free of connective tissue
and a small cut made to the cauda. The tissue was placed in 5 ml of culture medium
containing 0.1% BSA for 10 min at 37°C. An aliquot was placed on a pre-warmed slide
and gently cover-slipped. The specimen was immediately examined using phase contrast
microscopy with 100x magnification. All the motile sperm (i.e rapid progressive, slow
progressive, and non-progressive) were counted according to WHO category (S2). Percent
ratio of the motile sperm to the total number of sperm including immotile sperm was
calculated. Epididymal sperm count was determined using the same epididymis sample
according to a previously described method with some modifications (S3).
C. Histology
Tissues were fixed in Bouin’s (Sigma, St. Louis, MO), embedded in paraffin, sectioned
and then sections stained with hematoxylin and eosin according to standard procedures.
The Center for Reproductive Biology, Histology Core Laboratory assisted with these
procedures. The animal numbers are n = 50 for vinclozolin treatment and n = 42 for
controls.
D. Detection of Cell Apoptosis
To detect apoptotic cells in testis sections, the Fluorescein In Situ Cell Death Detection
Kit (Roche Applied Science, Indianapolis, IN) was utilized (S1). This system measures the
fragmented DNA from apoptotic cells by enzymatically incorporating fluorecein-12-dUTP
at the 3’-OH DNA ends using the enzyme terminal deoxynucleotidyl transferase which
forms a polymeric tail using the principle of the TUNEL assay. Fluorescent apoptotic cells
were imaged on a confocal microscope and number of apoptotic cells per testis cross
section determined. A minimum of n = 8 for vinclozolin and n = 6 for controls for each
generation was used. All cross sections used for TUNEL analysis had normal testis
morphology.
E. DNA Methylation Assays
The methylation status of DNA isolated from control and endocrine disruptor treated P6
testis or epididymal sperm was determined using a combination of methylation sensitive
restriction enzymes and a PCR approach previously described (S4, S5). Briefly, isolated
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genomic DNA was incubated and digested with Rsa I with either methylation-sensitive
(Hpa II) or insensitive (Msp I) restriction enzymes, followed by PCR with 10 primer sets
designed to amplify methylation sites. PCR products were electrophoretically separated
and visualized by SYBR green staining (Molecular Probes, Eugene, OR) and effects of
endocrine disruptors determined by the presence or absence of specific bands. The PCR
products of interest were isolated, cloned and sequenced to determine chromosomal
location using BLAST Genbank analysis (S6, S7). P6 testis analysis was repeated using 4
animals from different litters.
F. Bisulfite Sequencing
Genomic DNA was isolated from F1-F4 sperm samples using the DNeasy Tissue Kit
(Qiagen, Valencia, CA) and digested with Rsa I. Genomic DNA was then treated with
sodium bisulfite following methods previously established (S8). Briefly, 5 µg of digested
DNA was denatured in NaOH then treated with 4.0 M sodium metabisulfite pH 5.0 for 16
hours at 55°C. Following desalting, DNA was desulfonated with NaOH, neutralized and
precipitated with ammonium acetate and ethanol. DNA samples were resuspended in 30
µL of 1mM Tris buffer, pH 8.0. Sequence specific primers were generated to amplify the
region of interest. PCR products were cloned into pGEMT Easy vector (Promega
Corporation) and sequenced. Approximately 35 clones from each PCR product were
sequenced to determine the methylation state of the CpG sites. Confirming altered
methylation states involved comparisons of the sequences following the bisulfite
treatment. The primers for the lysophospholipase PCR bisulfite analysis were 5’GGT
ATA TAT AGA GGA AGG TAG GTA GG3’ and 5’TAA AAA CCT CCA AAA AAC
AAA CAC T3’.
G. Statistical Analysis
The data from apoptotic cell numbers, sperm motility and sperm count were analyzed
using a SAS program. The values were expressed as the mean ± SEM. Statistical analysis
was performed and the difference between the means of treatments and respective controls
was determined using two-way Analysis of Variance (ANOVA). Analysis performed with
JMP v3.1.6, SAS Institute Inc, Cary, NC. In vivo experiments were repeated with 6-30
individuals for each data point. A statistically significant difference was confirmed at P <
0.05.
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Fig. S1. Transgenerational phenotype after methoxychlor treatment. (A) Spermatogenic cell apoptosis. (B)
epididymal sperm counts. (C) Epididymal sperm motility in P60-P120 control and treated Fisher rats in F1
and F2 generations. Statistically significantly differences between control and treated animals within a
generation are indicated by (*) for P < 0.05. The number of animals for each bar ranged between 6 and 12.
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